surmount-1 tirzepatide weight loss nondiabetic SURMOUNT-1: Adults achieve of 16% or more at 72 weeks with Weight reduction over time in

You might feel a slight pinch during the IV insertion, but the infusion process itself is usually relaxed and pain-free.

Who you choose is important, so ensure that your values and cultures align

Avoid leaving your medication in a hot car, even briefly

Patient Selection and Monitoring Best Practices 503A pharmacy protocols should screen candidates for personal/family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2, as these contraindicate both agents regardless of perceived safety advantages

Only 19% of large employer plans covered GLP-1s for weight loss in 2025

The process isn't instant magic